While health chiefs prepare for a potential pandemic, China is testing a Russian anti-viral drug in the hope that it might help control the new coronavirus. It comes as prospects of a vaccine look slim for the foreseeable future.
Triazavirin, developed at Yekaterinburg’s Ural Federal University, was originally developed to combat ‘Bird Flu’ (H5N1), and, given that there are some similarities between the two infections, researchers feel it’s worth a punt. The medicine is already known to be effective against 15 types of flu.
Continue reading https://on.rt.com/aaed